Help | RSS Feed



Innovus Pharmaceuticals, Inc. (OTCMKT:INNV) Seasonal Chart

Innovus Pharmaceuticals, Inc. (OTCMKT:INNV) Seasonality

INNV Relative to the S&P 500
INNV Relative to the S&P 500

INNV Relative to the Sector
INNV Relative to the Sector

Monthly Seasonal Innovus Pharmaceuticals, Inc. (OTCMKT:INNV)

Seasonal Chart Analysis

Analysis of the Innovus Pharmaceuticals, Inc. (OTCMKT:INNV) seasonal charts above shows that a Buy Date of April 28 and a Sell Date of July 26 has resulted in a geometric average return of 40.41% above the benchmark rate of the S&P 500 Total Return Index over the past 8 years. This seasonal timeframe has shown positive results compared to the benchmark in 6 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 8 years by an average of 56.32% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

A word of caution: Only 8 years of data is available for shares of INNV, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

Innovus Pharmaceuticals Inc is a pharmaceutical company engaged in the
commercialization, licensing, and development of prescription and
non-prescription medicine and consumer care products.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...
Seasonal Advantage Portfolio by CastleMoore